RNAi-directed mRNA Cleavage
ACTL7B siRNA and shRNA Plasmids (h)
- Target species: human
- Gene Silencers generally consist of pools of three to five target-specific 19-25 nucleotide sequences in length
- For independent verification of ACTL7B gene silencing results, individual duplex components or plasmids are also available upon request
- Suitable control antibody: ACTL7B Antibody (F-1): sc-398446 is recommended as control antibody for monitoring of ACTL7B expression knockdown by Western blotting or immunofluorescence
- Get details about si/shRNA Gene Silencers
- Gene silencers are intended for noncommercial and research use only. Click here for details.
QUICK LINKS
Ordering Information
siRNA
Primer
shRNA Plasmid
shRNA Lentiviral Particles
Recommended Control Antibody
SEE ALSO...
ACTL7B Antibodies for analysis of cellular responses to ACTL7B si/shRNA Gene Silencers
Description
- 10 µM, 50-100 transfections
- siRNA products generally consist of pools of three to five target-specific 19-25 nt siRNAs designed to knockdown gene expression
- for independent verification of ACTL7B gene silencing results, individual siRNA duplex components are also available upon request
- suitable control antibody: ACTL7B Antibody (F-1): sc-398446
- sqRT-PCR Primer also available: ACTL7B (h)-PR: sc-92677-PR, 20 µl
- Get details about si/shRNA Gene Silencers
See Protocol Online.
DOWNLOADS
QUICK LINKS
Related Products
Description
- 20 µl of each primer set is provided at a concentration of 10 µM
- ACTL7B Primer (h) includes A set (forward & reverse) and B set (forward & reverse) primers
- Primer sets are recommended for semi-quantitative nested reverse transcriptase PCR
See Protocol Online.
DOWNLOADS
QUICK LINKS
Related Products
Description
- 20 µg, up to 20 transfections
- shRNA Plasmids generally consist of a pool of three to five lentiviral vector plasmids each encoding target-specific 19-25 nt (plus hairpin) shRNAs designed to knockdown gene expression
- shRNA sequences correspond to ACTL7B siRNA Gene Silencer sequences
- provided as transfection-ready purified plasmid DNA target-specific gene silencing
- after transfection, cells stably expressing shRNAs can be isolated by puromycin selection
- shRNA Plasmids are intended only for non-commercial use.
- suitable control antibody: ACTL7B Antibody (F-1): sc-398446
- sqRT-PCR Primer also available: ACTL7B (h)-PR: sc-92677-PR, 20 µl
See Protocol Online.
DOWNLOADS
QUICK LINKS
Related Products
Description
- 200 µl viral stock containing 1x 106 infectious units of virus (IFU) , sufficient for 10-20 transductions
- Lentiviral Particles are provided as transduction-ready viral particles for gene silencing
- Lentiviral Particles generally contain three to five expression constructs each encoding target-specific 19-25 nt (plus hairpin) shRNA designed to knockdown gene expression
- shRNA sequences correspond to ACTL7B siRNA Gene Silencer sequences
- After transduction, stable cell lines expressing the shRNA may be isolated via selection with puromycin
- Biosafety - Lentiviral Particles are replication-incompetent and are designed to self-inactivate after transduction and integration of shRNA constructs into genomic DNA of target cells.
- Lentiviral Particles are intended for non-commercial use.
See Protocol Online.
DOWNLOADS
QUICK LINKS
Related Products
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
ACTL7B siRNA (h) | sc-92677 | 10 µM | $298.00 | |||
ACTL7B (h)-PR | sc-92677-PR | 10 µM, 20 µl | $34.00 | |||
ACTL7B shRNA Plasmid (h) | sc-92677-SH | 20 µg | $603.00 | |||
ACTL7B shRNA (h) Lentiviral Particles | sc-92677-V | 200 µl | $725.00 |